|
||||||||
Company Profile | ||||||||
Chairman | CEO | Spokesperson | Tel | Address | Date of Listing (Regular) | |||
---|---|---|---|---|---|---|---|---|
CHOU CHIEN-CHUN | Joseph C. Hsu | CHOU CHIEN-CHUN | 04-23281939 | Room A, 10F., No. 51, GongYi Road SEction 2, NanTun,Taichung, Taiwan 408 | 2003/03/31 | |||
Industry | Main Business | |||||||
Other | Neith Corp.,The Biomedical Dept. supplies medical device,stone SPA and peripherals,negative ion products,skin care products and dietary supplement. Based on the mission of "developing Taiwanese spirit, international marketing, and contributing to Taiwan", we make the Taiwan’s top products by utilizing the best materials, excellent talents and resources in Taiwan. We are dedicated to providing high-quality MIT products for not only local customers but also overseas customers, and will help the Taiwanese people who need help indeed. Neith Corp. scale is growing steadily with this spirit, which is reflected in our logo. We are like eagles, nested in Taiwan, but soaring in the international sky, manifesting the Taiwanese spirit. |
Market Information ( 2024/04/19 ) | |||||||||||
Shr. Vol. | Highest | Lowest | Closed | Change | Transaction | TurnOver(%) | long margin balance (1,000shr.) |
Short margin balance (1,000shr.) |
|||
---|---|---|---|---|---|---|---|---|---|---|---|
15 | 33.90 | 31.80 | 33.90 | -0.60 | 5 | .00 | N/A | N/A | |||
Trading method | Fun purchase price or securities pneeded on T day |
Announcement of Irregularity (2024/04/19) |
TPEx measures adopted (2024/04/19) |
With warrants | Can be shorted or margined? | Detail | |||||
變更交易 | Y | N | N | N | N | Today | History |
Financial Reports | |||||
---|---|---|---|---|---|
Cash Flows | Items | ||||
Amount (NT$ thousand) |
|||||
Cash flows from operating activities | |||||
Cash flows from investing activities | |||||
Cash flows from financing activities | |||||
Balance Sheets |
Current assets | ||||
Non-current assets | |||||
Total assets | |||||
Current liabilities | |||||
Non-current liabilities | |||||
Total liabilities | |||||
Share capital | |||||
Capital surplus | |||||
Retained earnings | |||||
Other equity interest | |||||
Treasury shares | |||||
Total equity attributable to owners of parent | |||||
Non-controlling interests | |||||
Total equity | |||||
Book Value per share(NT$) | |||||
Comprehensive Income | Operating revenue | ||||
Operating costs | |||||
Gross profit from operations | |||||
Operating expenses | |||||
Net other income (expenses) | |||||
Net operating income | |||||
Non-operating income and expenses | |||||
Profit before tax | |||||
Tax expense | |||||
Profit from continuing operations | |||||
Profit from discontinued operations | |||||
Profit | |||||
Other comprehensive income | |||||
Comprehensive income | |||||
Basic earnings per share |
Auditor's report on latest financial statements: auditor's report: |
More detail:MOPS。 |
Foreign issuers’ information is disclosed in consolidated statements. |